{"product_id":"admedsol-business-model-canvas","title":"Advanced Medical Solutions Group Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBusiness Model Canvas Preview: Value Propositions, Customer Segments \u0026amp; Revenue Drivers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the strategic core of Advanced Medical Solutions Group with our Business Model Canvas—three to five sentences can't capture the full picture, but this preview shows value propositions, customer segments, and revenue drivers. Purchase the complete Word\/Excel canvas for a section-by-section playbook ideal for investors, consultants, and founders seeking actionable insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiomaterial and component suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSecure relationships with polymer, cyanoacrylate, collagen\/alginate and foam suppliers ensure regulatory-grade inputs compliant with ISO 13485:2016 and EU MDR requirements in 2024. Dual-sourcing critical materials reduces single-supplier exposure and supports continuity of supply. Collaborate on co-development of novel substrates and coatings focused on infection prevention and lock long-term agreements to stabilise pricing and lead times.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospitals, surgeons, and KOL networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEngage surgical leaders to guide product design and usability, leveraging input from clinicians who perform procedures within the 300+ million global surgeries annually to ensure fit-for-purpose solutions. Partner on multicenter clinical evaluations to build real-world evidence and support reimbursement discussions. Use KOL advocacy to drive guideline inclusion and accelerate adoption. Co-create standardized training content with hospitals and surgeons to embed best practices.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOEM\/private-label medtech partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eProvide adhesives, dressings and sutures as white-label or co-branded solutions, leveraging AMS Group’s OEM model to fill portfolio gaps for large device companies. Align joint roadmaps to prioritize launches where AMS clinical\/regulatory assets cut time-to-market; AMS reported 2024 revenue of £62.8m and aims to scale via partner channels into 60+ territories. This avoids duplicative infrastructure and accelerates global roll-out.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory bodies and notified bodies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpmaintain proactive dialogue with eu notified bodies designated by mid-2024 and fda to secure approvals stay ahead of mdr updates align qms technical files expectations engage in consultations anticipate classification shifts target faster review cycles reducing time-to-market versus ad hoc routes.\u003e\n\u003cp\u003e\u003c\/p\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRegulatory engagement: ongoing with 20+ MDR notified bodies (mid-2024)\u003c\/li\u003e\n\u003cli\u003eQMS alignment: updated to 2024 MDR\/FDA norms\u003c\/li\u003e\n\u003cli\u003eConsultations: proactive to foresee classification changes\u003c\/li\u003e\n\u003cli\u003eFaster access: aim for 30-40% shorter review times\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pmaintain\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal distributors and tender aggregators\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSelect and partner with capable distributors in regions without direct sales, aligning on demand planning, pricing discipline and distributor training to protect margins and brand standards. Coordinate tender submissions and manage post-award service obligations with clear roles and inventory commitments. Monitor performance through SLAs and field metrics (OTD, fill rate, complaint resolution) to drive continuous improvement.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDistributor selection and capability assessment\u003c\/li\u003e\n\u003cli\u003eJoint demand planning, pricing governance, training\u003c\/li\u003e\n\u003cli\u003eCollaborative tender bids and post-award support\u003c\/li\u003e\n\u003cli\u003eSLAs + field metrics (on-time delivery, fill rate, claim rate)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDual-sourced supply and \u003cstrong\u003e20+\u003c\/strong\u003e regulatory engagements drive rapid global rollout\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSecure dual-sourced suppliers (polymers, cyanoacrylates, collagen, foam) and 20+ notified-body\/regulatory engagements to meet ISO 13485\/MDR\/FDA norms; AMS 2024 revenue £62.8m and rollout into 60+ territories. Clinical KOLs and multicenter studies leverage 300+ million global surgeries to drive adoption and reimbursement. Distributor SLAs and OEM partnerships shorten time-to-market by 30-40%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 revenue\u003c\/td\u003e\n\u003ctd\u003e£62.8m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTerritories\u003c\/td\u003e\n\u003ctd\u003e60+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNotified bodies\u003c\/td\u003e\n\u003ctd\u003e20+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal surgeries\u003c\/td\u003e\n\u003ctd\u003e300+ million\/yr\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReview time reduction\u003c\/td\u003e\n\u003ctd\u003e30-40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive, pre-written Business Model Canvas for Advanced Medical Solutions Group, detailing customer segments, channels, value propositions, revenue streams, resources, activities, partners, cost structure and customer relationships. Designed for presentations and investor discussions, it links SWOT and competitive advantages to each BMC block to support strategic decisions and validation using real company context.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of Advanced Medical Solutions Group’s business model with editable cells, helping teams quickly pinpoint product, customer and regulatory pain points and streamline R\u0026amp;D, manufacturing and go-to-market decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eR\u0026amp;D and product innovation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDesign advanced wound dressings, tissue adhesives and fixation solutions focused on polymer-led innovations, iterating formulations to optimize antimicrobial efficacy and biocompatibility while aligning with 2024 regulatory expectations.\u003c\/p\u003e\n\u003cp\u003eRun targeted usability studies in the OR to streamline workflow and reduce procedure time and complications, feeding real-world feedback into product cycles.\u003c\/p\u003e\n\u003cp\u003eBuild differentiated claims backed by bench and clinical data, prioritising CE\/510(k) pathways and value-based endpoints to support uptake and reimbursement.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory, quality, and clinical affairs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePrepare and maintain technical documentation to comply with EU MDR 2017\/745 (in force 26 May 2021) and ISO 13485:2016, managing notified body and supplier audits on an ongoing basis. Conduct clinical studies and PMCF to sustain indications, aligning study designs with MDCG guidance and typical PMCF cohorts ranging from small registries to multicenter studies. Maintain vigilant post-market surveillance and CAPA processes with KPI targets such as CAPA cycle-times under 30 days and 100% adverse-event reporting compliance. Ensure sterilization validation per ISO 11135 and full lot traceability across manufacturing and distribution.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and supply chain\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAs of 2024 Advanced Medical Solutions operates GMP facilities for coating, compounding and assembly, supporting regulated woundcare and surgical product lines. The group controls COGS through yield improvement programs and automation investments that target continuous efficiency gains. Suppliers are qualified and sterile packaging plus logistics are centrally managed with site redundancy to mitigate shortages and maintain supply continuity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommercial execution and tendering\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePursue hospital tenders and GPO contracts with focused bid teams, train sales on value-based messaging to drive clinical and economic adoption, and manage pricing, reimbursement dossiers and health-economic evidence to secure formulary placement. Support conversions and on-site evaluations at key accounts to shorten sales cycles and demonstrate outcomes.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTenders \u0026amp; GPOs\u003c\/li\u003e\n\u003cli\u003eValue-based sales training\u003c\/li\u003e\n\u003cli\u003ePricing \u0026amp; HEOR dossiers\u003c\/li\u003e\n\u003cli\u003eAccount conversions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical education and clinician support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eDeliver workshops, in-service training and e-learning modules to accelerate device proficiency; global e-learning market reached about $318 billion in 2024, highlighting scale for digital clinician education.\u003c\/p\u003e\n\u003cp\u003eProvide procedural guides and on-call troubleshooting, capture structured feedback for continuous improvement, and drive adoption via peer-led case studies and educator networks.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eWorkshops\u003c\/li\u003e\n\u003cli\u003eProcedural guides\u003c\/li\u003e\n\u003cli\u003eFeedback loops\u003c\/li\u003e\n\u003cli\u003eCase-study adoption\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePolymer wound-care: GMP coating, PMCF evidence, CAPA \u0026lt;30 days\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDesign and iterate polymer-led wound dressings, adhesives and fixation solutions to meet 2024 regulatory expectations and antimicrobial\/biocompatibility targets.\u003c\/p\u003e\n\u003cp\u003eRun OR usability studies and PMCF registries to shorten procedures and build value-based clinical claims supporting CE\/510(k) pathways.\u003c\/p\u003e\n\u003cp\u003eOperate GMP coating\/assembly sites, enforce CAPA \u0026lt;30-day targets and 100% adverse-event reporting while pursuing tenders, HEOR dossiers and clinician training.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 Target\/Fact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCAPA cycle-time\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;30 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAE reporting\u003c\/td\u003e\n\u003ctd\u003e100% compliance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal e-learning market\u003c\/td\u003e\n\u003ctd\u003e$318B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the actual Advanced Medical Solutions Group Business Model Canvas you'll receive after purchase. It's not a mockup—this live preview shows the same structured, editable file delivered to you in Word and Excel formats. Upon completing your order you'll gain instant access to the full document, ready for editing, presenting, and sharing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56162329788793,"sku":"admedsol-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/admedsol-business-model-canvas.png?v=1762699074","url":"https:\/\/portersfiveforce.com\/products\/admedsol-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}